Loading clinical trials...
Loading clinical trials...
Dalfampridine to Improve Imbalance in Multiple Sclerosis: A Pilot Study
Conditions
Interventions
Dalfampridine
Placebo
Locations
1
United States
Oregon Health and Science University
Portland, Oregon, United States
Start Date
September 1, 2011
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2013
Last Updated
June 16, 2014
NCT06276634
NCT07225504
NCT06809192
NCT06082518
NCT05359653
NCT07376772
Lead Sponsor
Oregon Health and Science University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions